Por favor, use este identificador para citar o enlazar este ítem: http://hdl.handle.net/10201/53178

Título: Argyrophilic nucleolar organizer region (AgNOR) counting in astrocytic gliomas: prognostic value
Fecha de publicación: 1996
Editorial: Murcia : F. Hernández
ISSN: 0213-3911
Materias relacionadas: CDU::6 - Ciencias aplicadas::61 - Medicina::616 - Patología. Medicina clínica. Oncología
Palabras clave: AgNOR
Astrocytoma
Resumen: In 87 astrocytic gliomas the number of AgNORs/nucleus was retrospectively studied and data correlated with the histological type of the tumors and survival. Al1 patients were treated by the same surgical team and with uniform criteria. Statistically significant differences (p<0.01) were found in relation with the AgNOR averages among the histological types of tumors. A statistically significant linear correlation (p<0.05) between the AgNOR values and survival of the patients was also found. Patients with mean AgNOR values higher than 2.23 and lower than 2.9 survived an average of 11.5I9.1 months vs. a sumival in average of 24.4I34.1 months with mean AgNOR values under 2.23 (p<0.05). Patients with AgNOR values higher than 2.9 survived, on average, 7.7I3.9 months. AgNOR counting in astrocytic gliomas is a reproducible, easy, quick method with prognostic value. AgNORs may be successfully applied in routine material to assess the growth potential of astrocytic gliomas.
Autor/es principal/es: Cardesa, Antonio
Ferreres, Joan-Carles
Figols, J.
Val-Bernal, José Fernando
Cruz Sánchez, F.F.
Publicado en: Histology and histopathology
URI: http://hdl.handle.net/10201/53178
Tipo de documento: info:eu-repo/semantics/article
Número páginas / Extensión: 5
Derechos: info:eu-repo/semantics/openAccess
Aparece en las colecciones:Vol.11, nº 1 (1996)

Ficheros en este ítem:
Fichero Descripción TamañoFormato 
Argyrophilic nucleolar organizer region AgNOR counting in astrocytic gliomas prognostic value.pdf2,91 MBAdobe PDFVista previa
Visualizar/Abrir


Los ítems de Digitum están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.